Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evident Vascular is a medical technology company developing an artificial intelligence-powered intravascular ultrasound (IVUS) platform designed to optimize vascular imaging. Headquartered in San Jose, California, the company was incubated by Vensana Capital to address the limitations of legacy IVUS systems, such as poor image quality and complex clinical workflows. Its flagship product, the Evident Vascular Guidance System, utilizes advanced AI algorithms to automatically identify and segment key vascular structures, providing clinicians with real-time insights during peripheral and coronary interventions. By enhancing image interpretation and ease of use, the platform aims to expand the adoption of IVUS and improve outcomes for patients with peripheral arterial and venous diseases. The company is currently advancing its technology toward FDA 510(k) clearance for a planned U.S. market launch.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evident Vascular.